Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing–remitting multiple sclerosis (RRMS)

por Gold, Ralf, Giovannoni, Gavin, Phillips, J Theodore, Fox, Robert J, Zhang, Annie, Meltzer, Leslie, Kurukulasuriya, Nuwan C
Publicado 2015

Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience

por Gold, Ralf, Phillips, J. Theodore, Havrdova, Eva, Bar-Or, Amit, Kappos, Ludwig, Kim, Norman, Thullen, Tim, Valencia, Patricia, Oliva, Lauren, Novas, Mark, Li, Jie, Sweetser, Marianne T., Kurukulasuriya, Nuwan, Viglietta, Vissia, Fox, Robert J.
Publicado 2015

RE-MIND: Comparing Tafasitamab + Lenalidomide (L-MIND) with a Real-world Lenalidomide Monotherapy Cohort in Relapsed or Refractory Diffuse Large B-cell Lymphoma

por Zinzani, Pier Luigi, Rodgers, Thomas, Marino, Dario, Frezzato, Maurizio, Barbui, Anna Maria, Castellino, Claudia, Meli, Erika, Fowler, Nathan H., Salles, Gilles, Feinberg, Bruce, Kurukulasuriya, Nuwan C., Tillmanns, Sascha, Parche, Stephan, Dey, Debarshi, Fingerle-Rowson, Günter, Ambarkhane, Sumeet, Winderlich, Mark, Nowakowski, Grzegorz S.
Publicado 2021

Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study

por Nowakowski, Grzegorz S., Yoon, Dok Hyun, Peters, Anthea, Mondello, Patrizia, Joffe, Erel, Fleury, Isabelle, Greil, Richard, Ku, Matthew, Marks, Reinhard, Kim, Kibum, Zinzani, Pier Luigi, Trotman, Judith, Huang, Dan, Waltl, Eva E., Winderlich, Mark, Kurukulasuriya, Nuwan C., Ambarkhane, Sumeet, Hess, Georg, Salles, Gilles
Publicado 2022

RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) b...

por Nowakowski, Grzegorz S., Yoon, Dok Hyun, Mondello, Patrizia, Joffe, Erel, Peters, Anthea, Fleury, Isabelle, Greil, Richard, Ku, Matthew, Marks, Reinhard, Kim, Kibum, Zinzani, Pier Luigi, Trotman, Judith, Sabatelli, Lorenzo, Waltl, Eva E., Winderlich, Mark, Sporchia, Andrea, Kurukulasuriya, Nuwan C., Cordoba, Raul, Hess, Georg, Salles, Gilles
Publicado 2023

Correction to: RE‑MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola‑BR), CAR‑T therapies, and lenalidomide/r...

por Nowakowski, Grzegorz S., Yoon, Dok Hyun, Mondello, Patrizia, Joffe, Erel, Peters, Anthea, Fleury, Isabelle, Greil, Richard, Ku, Matthew, Marks, Reinhard, Kim, Kibum, Zinzani, Pier Luigi, Trotman, Judith, Sabatelli, Lorenzo, Waltl, Eva E., Winderlich, Mark, Sporchia, Andrea, Kurukulasuriya, Nuwan C., Cordoba, Raul, Hess, Georg, Salles, Gilles
Publicado 2023

Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study

por Gold, Ralf, Arnold, Douglas L, Bar-Or, Amit, Hutchinson, Michael, Kappos, Ludwig, Havrdova, Eva, MacManus, David G, Yousry, Tarek A, Pozzilli, Carlo, Selmaj, Krysztof, Sweetser, Marianne T, Zhang, Ray, Yang, Minhua, Potts, James, Novas, Mark, Miller, David H, Kurukulasuriya, Nuwan C, Fox, Robert J, Phillips, Theodore J
Publicado 2016